NLRP3 and neoplasm: To overcome these barriers, nanoparticle-mediated delivery can enhance tumor-specific targeting, and simultaneous modulation of synergistic ncRNA axes (e.g., SIRT1–NLRP3-related pathways) may amplify therapeutic effects.